- The new Roche Anti-SARS-CoV-2 S test launched in January 2021 can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been vaccinated against or exposed to the virus.
- The test targets antibodies against the Nucleocapsid and Receptor Binding Domain Spike antigen protein.
- Used in global pharmaceutical clinical trials to confirm vaccine efficacy – the majority of current vaccines aim to induce an antibody response against the spike protein which can be measured by this test.
- This self-collection blood kit enables determination of both the presence and level of antibodies to the COVID spike protein from a finger prick blood sample, unlike other antibody tests which only confirm a positive or negative result.
- CE Marked and MHRA approved.
- Samples returned to our UKAS accredited lab by Royal Mail Tracked 24 response (mailer/label included) using any Royal Mail post box.
- Results available within 24 hours after sample received by lab.
- Manufactured by MedDX Solutions Ltd.